Catarina M Quinzii Selected Research

coenzyme Q10 (CoQ10)

11/2020	Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism.
1/2020	Redefining infantile-onset multisystem phenotypes of coenzyme Q10-deficiency in the next-generation sequencing era.
1/2019	Primary coenzyme Q10 deficiency-7: expanded phenotypic spectrum and a founder mutation in southern Chinese.
12/2018	Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy.
11/2018	CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway.
1/2017	A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.
1/2016	Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum.
1/2016	CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome.
1/2016	Coenzyme Q10 as a Peripheral Biomarker for Multiple System Atrophy.
8/2015	Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catarina M Quinzii Research Topics

Disease

14	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 05/2009
11	Coenzyme Q10 Deficiency 01/2021 - 03/2008
9	Cerebellar Ataxia (Dysmetria) 01/2019 - 06/2007
8	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
7	Muscular Diseases (Myopathy) 02/2015 - 06/2007
6	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 12/2006
5	Neoplasms (Cancer) 01/2021 - 01/2018
3	Renal Insufficiency (Renal Failure) 01/2021 - 01/2017
3	Ataxia (Dyssynergia) 08/2015 - 03/2008
2	Brain Diseases (Brain Disorder) 01/2020 - 10/2012
2	Mitochondrial Myopathies (Mitochondrial Myopathy) 11/2019 - 05/2015
2	Muscle Weakness 01/2017 - 02/2015
2	Multiple System Atrophy 01/2016 - 01/2016
2	Lactic Acidosis 10/2012 - 05/2009
1	Kidney Diseases (Kidney Disease) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2020
1	Critical Illness (Critically Ill) 11/2019
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Frailty 11/2019
1	Carcinoma (Carcinomatosis) 10/2019
1	Melanoma (Melanoma, Malignant) 10/2019
1	Multiple Sclerosis 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Chronic Renal Insufficiency 11/2018
1	Muscle Hypotonia (Hypotonia) 01/2017
1	Dystonia (Limb Dystonia) 01/2017
1	Deafness (Deaf Mutism) 01/2017
1	Movement Disorders (Movement Disorder) 01/2017
1	Glut1 Deficiency Syndrome 01/2016
1	Essential Tremor (Essential Tremors) 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Neuroblastoma 08/2015
1	Apraxias (Dyspraxia) 08/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2012
1	Seizures (Absence Seizure) 05/2009
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2009
1	X-Linked Dominant Scapuloperoneal Myopathy 01/2008
1	Deficiency Diseases (Deficiency Disease) 06/2007
1	Leigh Disease (Leigh's Disease) 12/2006

Drug/Important Bio-Agent (IBA)

19	coenzyme Q10 (CoQ10)IBA 11/2020 - 12/2006
8	UbiquinoneIBA 03/2022 - 03/2008
6	EnzymesIBA 03/2022 - 12/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2008
4	Sulfides (Thioethers)IBA 11/2020 - 01/2017
3	Glutathione (Reduced Glutathione)IBA 01/2021 - 01/2017
2	CarbonIBA 11/2020 - 10/2019
2	PanobinostatIBA 10/2020 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2008
2	CrizotinibIBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2016
2	navitoclaxIBA 10/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2016
2	Mitochondrial DNA (mtDNA)IBA 01/2017 - 02/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2017 - 03/2008
2	ubiquinone 9IBA 05/2015 - 05/2009
1	Biological ProductsIBA 03/2022
1	Aurora Kinase AIBA 01/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	2- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- olIBA 01/2021
1	Therapeutic UsesIBA 11/2020
1	sulfide quinone reductaseIBA 11/2020
1	romidepsin (FK228)FDA Link 10/2020
1	Protons (Proton)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Growth Differentiation Factor 15IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	CholesterolIBA 10/2019
1	Liver X ReceptorsIBA 10/2019
1	2- (2- chloro- 4- fluorobenzyl)- 3- (4- fluorophenyl)- 7- (trifluoromethyl)- 2H- indazoleIBA 10/2019
1	GW 3965IBA 10/2019
1	CeramidesIBA 01/2019
1	AntioxidantsIBA 01/2019
1	IntegrinsIBA 01/2019
1	Drug CombinationsIBA 11/2018
1	Oxidoreductases (Dehydrogenase)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	quinone (benzoquinone)IBA 11/2018
1	ONC206IBA 11/2018
1	ONC212IBA 11/2018
1	OTX015IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 08/2015
1	AnoctaminsIBA 11/2014
1	Chloride Channels (Chloride Channel)IBA 11/2014
1	Coenzymes (Enzyme Cofactors)IBA 11/2014
1	Nonsense Codon (Nonsense Mutation)IBA 05/2009
1	decaprenyl pyrophosphate synthetaseIBA 12/2006

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2012
1	Exercise Therapy (Therapy, Exercise) 01/2018